Frequently asked questions
The global orthopedic biomaterials market was valued at USD 19145.8 Million in 2022.
The orthopedic biomaterials market is expected to grow at a CAGR of 9.7% between 2023 and 2030, reaching USD 40153.8 Million in 2030.
Metallic biomaterials is the leading segment by material type, holding over 30% share in value in 2022.
The orthopedic implants segment governs the global demand for orthopedic biomaterials, holding a massive market share of over 28% in 2022.
The orthopedic specialty centers segment will post the highest CAGR over the projection period.
North America contributes to the rapid growth of the orthopedic biomaterials industry, accounting for more than one-third of its market share in 2022.
The top players include Zimmer Biomet, Stryker, DePuy Synthes Companies, Medtronic, Arthrex Inc, NuVasive Inc, Globus Medical Inc, Evonik Industries AG, Victrex Plc, Collagen Matrix Inc, Heraeus Holding GmbH, and Others.
The major market drivers of the orthopedic biomaterials industry include the aging population, technological advancements, rising demand for orthopedic implants, and expanding applications in various orthopedic procedures.
The major market restraints of the orthopedic biomaterials industry include stringent regulatory approvals and compliance requirements, high development and manufacturing costs, competition, and the risk of adverse reactions.
The major market opportunities of the orthopedic biomaterials industry include emerging market growth, emerging technological innovations, increasing demand for customized solutions, and advancements in sustainable and biodegradable biomaterials.